theMednetRegister

Dermatology

Hematology   

Questions discussed in this category

Would you give adjuvant radiation after complete resection of a small primary cutaneous follicular lymphoma of the scalp?
If so, would you treat with 4 Gy or 24 Gy?
3 Answers available
How would you work up a patient with cutaneous mastocytosis?
Is a BM biopsy a must when there is skin involvement? If tryptase level is mildly elevated but less than 20 would you recommend a BM biopsy?
2 Answers available
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
2 Answers available
Have you seen CD30+ lymphoproliferative skin lesions with Upadacitinib treatment of atopic dermatitis?
1 Answer available
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
2 Answers available
How are you utilizing vibratory devices for reducing pain associated with injection or procedures?
In which situations or patient populations do you find this useful? How is it sterilized?
3 Answers available
What is your approach to evaluation in patients who present with erythromelalgia?
1 Answer available
What initial workup do you perform when there is a concern for porphyria?
1 Answer available
Do you hold histone deacetylase (HDAC) inhibitors for patients receiving palliative radiation therapy for cutaneous lymphomas?
If so, how long before/after radiation?
1 Answer available
How would you manage a patient with essential thrombocythemia and persistent pruritus despite adequate control of CBC with hydroxyurea and aspirin?
ET is JAK2+
1 Answer available
How do you differentiate atopic dermatitis from mycosis fungoides histologically?
1 Answer available
How long do you give systemic therapies or skin directed therapies to work before changing treatments in patients with diffuse skin limited mycoses fungoides?
Do you have a preferred sequence of therapies for diffuse skin limited MF?
1 Answer available
What is your escalation strategy for chronic GvHD?
How does belumosudil now fit in your approach to steroid refractory chronic graft-versus-host disease?
1 Answer available
Should venous thrombosis in a patient with Behcet syndrome be treated with both immunosuppression and anticoagulation?
1 Answer available
How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?
2 Answers available


Papers discussed in this category

JAMA network open, 2018-11-02
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
Transplant Cell Ther, 2021 Sep 02
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience.
Eur J Dermatol,
Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.
The journal of allergy and clinical immunology. In practice, 2020 Dec 23
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin.
Arthritis & rheumatology (Hoboken, N.J.), 2023 Jul 24
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
Blood, 2008-09-01
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
The Lancet. Oncology, 2021 Feb 01
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.

Related Topics in Dermatology

Copyright © 2025 theMednet
All Rights Reserved.